Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $110.07 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $101.24 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $29.01 | 2 | Novo Nordisk Inc ($29.01) |
| 2022 | $43.06 | 3 | Novo Nordisk Inc ($43.06) |
| 2021 | $38.00 | 3 | Novo Nordisk Inc ($29.17) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Obesity | ||||||
| 06/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
| 05/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 03/31/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 01/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 12/06/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Diabetes | ||||||
| 11/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Virology & Specialty Care | ||||||
| 10/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 823 | 1,403 | $229,390 | $45,186 |
| 2022 | 18 | 858 | 1,419 | $209,440 | $42,734 |
| 2021 | 19 | 929 | 1,523 | $224,046 | $56,508 |
| 2020 | 16 | 966 | 1,451 | $198,820 | $43,861 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 425 | $116,045 | $19,690 | 17.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $35,593 | $9,545 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 79 | $30,430 | $5,182 | 17.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $9,142 | $3,081 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 152 | 323 | $8,350 | $2,713 | 32.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $4,312 | $1,141 | 26.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 24 | $3,393 | $830.88 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,409 | $724.89 | 16.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 82 | $4,477 | $659.59 | 14.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 13 | 13 | $1,333 | $433.51 | 32.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $1,222 | $396.76 | 32.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $1,200 | $389.28 | 32.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 21 | 23 | $1,104 | $126.56 | 11.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 35 | $977.00 | $119.35 | 12.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $814.00 | $93.85 | 11.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 28 | 51 | $1,981 | $50.39 | 2.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 96 | $4,608 | $8.49 | 0.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 405 | $104,894 | $18,718 | 17.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $29,817 | $8,298 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 63 | $23,335 | $4,019 | 17.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 54 | 64 | $9,600 | $2,231 | 23.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $5,480 | $1,937 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $5,994 | $1,377 | 23.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 71 | 71 | $3,942 | $1,071 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 148 | 298 | $5,386 | $882.78 | 16.4% |
About Angela Meeks, NP
Angela Meeks, NP is a Family healthcare provider based in Monroe, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1467838334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Meeks, NP has received a total of $110.07 in payments from pharmaceutical and medical device companies, with $29.01 received in 2023. These payments were reported across 8 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($110.07).
As a Medicare-enrolled provider, Meeks has provided services to 3,576 Medicare beneficiaries, totaling 5,796 services with total Medicare billing of $188,289. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Monroe, GA
- Active Since 08/03/2015
- Last Updated 01/14/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1467838334
Products in Payments
- Ozempic (Drug) $43.89
- Rybelsus (Drug) $29.70
- RYBELSUS (Drug) $13.88
- Wegovy (Drug) $13.77
- Xofluza (Drug) $8.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Monroe
Mr. Tavell Kindall, Fnp-Bc, FNP-BC
Family — Payments: $129,737
Lane Judge, Fnp-C, FNP-C
Family — Payments: $37,930
Gabrielle Nicolle
Family — Payments: $11,324
Mrs. Jereta Lawrence, Fnp-C, FNP-C
Family — Payments: $11,016
Mrs. Catherine Midyett, Fnp, FNP
Family — Payments: $10,122
Kate Breiner, Np, NP
Family — Payments: $7,853